Healthcare
Live Price
Offline$2.31
-2.53% today
1Y Change
-6.00%
Window
Jun 20, 2025 → Jun 15, 2026
Coverage: 247 bars · Jun 20, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
XBiotech Inc. (XBIT) is a Healthcare stock with a market cap of $80.00M and listed on NASDAQ. The stock last traded around $2.31 and down 6.0% across the available one-year price window (Jun 20, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -18.3%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -18.3%, free cash flow -24.6% with operating margin 0.0% and ROIC -39.2%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines XBIT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
XBIT
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
XBIT Max Drawdown
-39.43%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for XBIT and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
Latest Revenue
—
Latest Net Income
—
Free Cash Flow
—
Revenue Growth
+0.0%
EPS Growth
-18.3%
Gross Margin
0.0%
Net Margin
0.0%
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.